Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kung

Showing results (191-200 of 378) with videos related to

Pageof 38
Sort By:
American Journal of Clinical Pathology|October 12, 2002
Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 casesGary M K Tse, C Soon Lee, Fred Y L Kung, et al.
Science (New York, N.Y.)|September 9, 2004
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helixLoren D Walensky, Andrew L Kung, Iris Escher, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2003
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumorsJoshua B Rubin, Andrew L Kung, Robyn S Klein, et al.
Cancer Cell|August 17, 2013
A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cellsFabio Petrocca, Gabriel Altschuler, Shen Mynn Tan, et al.
Plos Medicine|April 12, 2007
Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcomaKimberly Stegmaier, Jenny S Wong, Kenneth N Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2008
Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiationCynthia K Hahn, Kenneth N Ross, Ian M Warrington, et al.
Molecular Cancer Therapeutics|May 1, 2008
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cellsEllen Weisberg, Renee D Wright, Douglas W McMillin, et al.
AJR. American Journal of Roentgenology|October 24, 2003
Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumorsGary M K Tse, Humairah S Cheung, Lai-Man Pang, et al.
Blood|August 21, 2012
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaChristopher J Ott, Nadja Kopp, Liat Bird, et al.
Pediatric Blood & Cancer|April 3, 2015
Overcoming challenges to meaningful informed consent for whole genome sequencing in pediatric cancer researchJennifer A Oberg, Julia L Glade Bender, Elizabeth G Cohn, et al.
Pageof 38

Showing results (191-200 of 378) with videos related to

Sort By:
Pageof 38
American Journal of Clinical Pathology|October 12, 2002
Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 casesGary M K Tse, C Soon Lee, Fred Y L Kung, et al.
Science (New York, N.Y.)|September 9, 2004
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helixLoren D Walensky, Andrew L Kung, Iris Escher, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2003
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumorsJoshua B Rubin, Andrew L Kung, Robyn S Klein, et al.
Cancer Cell|August 17, 2013
A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cellsFabio Petrocca, Gabriel Altschuler, Shen Mynn Tan, et al.
Plos Medicine|April 12, 2007
Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcomaKimberly Stegmaier, Jenny S Wong, Kenneth N Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2008
Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiationCynthia K Hahn, Kenneth N Ross, Ian M Warrington, et al.
Molecular Cancer Therapeutics|May 1, 2008
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cellsEllen Weisberg, Renee D Wright, Douglas W McMillin, et al.
AJR. American Journal of Roentgenology|October 24, 2003
Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumorsGary M K Tse, Humairah S Cheung, Lai-Man Pang, et al.
Blood|August 21, 2012
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaChristopher J Ott, Nadja Kopp, Liat Bird, et al.
Pediatric Blood & Cancer|April 3, 2015
Overcoming challenges to meaningful informed consent for whole genome sequencing in pediatric cancer researchJennifer A Oberg, Julia L Glade Bender, Elizabeth G Cohn, et al.
Pageof 38